Statistics

Total Visits

Views
Switching to dual therapy (atazanavir/ritonavir+lamivudine) vs. standard triple therapy (atazanavir/ritonavir+2 nucleos[t]ides) is safe and effective in virologically suppressed patients: 48-week results of a randomized clinical trial (SALT study)9

Select a period of time:

Number of views in the range

Views
Switching to dual therapy (atazanavir/ritonavir+lamivudine) vs. standard triple therapy (atazanavir/ritonavir+2 nucleos[t]ides) is safe and effective in virologically suppressed patients: 48-week results of a randomized clinical trial (SALT study)3

Views

Views
November 20231
December 20230
January 20240
February 20240
March 20241
April 20240
May 20241
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States3
 

Top cities views

Views
Ashburn1